# Domperidone Expanded Access Program for Oncology Patients With Gastroparesis Who Have Failed Standard Therapy

> **NCT02494687** · — · AVAILABLE · sponsor: **Eastern Regional Medical Center**

## Conditions studied

- Oncology Patients With Gastroparesis

## Interventions

- **DRUG:** Oral Domperidone
- **DRUG:** Oral Domperidone
- **DRUG:** Oral Domperidone

## Key facts

- **NCT ID:** NCT02494687
- **Lead sponsor:** Eastern Regional Medical Center
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** EXPANDED_ACCESS
- **Status:** AVAILABLE
- **Start date:** —
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** — (—)
- **Last updated:** 2020-03-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02494687

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02494687, "Domperidone Expanded Access Program for Oncology Patients With Gastroparesis Who Have Failed Standard Therapy". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02494687. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*